Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2024 Filed Feb 2, 2024 21:25 UTC |
Skovronsky DanielEVP, CSO & Pres. LRL & LLY Imm
|
Tax withholdingCommon Stock | 4,434 | $645.61 | $2,862,634.74 |
DisclosureSEC source: 0000059478-24-000019 · wk-form4_1706909126.xml · nonDerivative · entry 2 Skovronsky Daniel · CIK 0001741474 · EVP, CSO & Pres. LRL & LLY Imm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,828 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:25 UTC |
Skovronsky DanielEVP, CSO & Pres. LRL & LLY Imm
|
Exercise / conversionCommon Stock | 9,941 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000019 · wk-form4_1706909126.xml · nonDerivative · entry 1 Skovronsky Daniel · CIK 0001741474 · EVP, CSO & Pres. LRL & LLY Imm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:26 UTC |
Jonsson PatrikEVP&Pres, LLY Dia&Obe, LLY USA
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,124 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000021 · wk-form4_1706909191.xml · derivative · entry 4 Jonsson Patrik · CIK 0001786054 · EVP&Pres, LLY Dia&Obe, LLY USA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,124 shares Expires 2024-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:26 UTC |
Jonsson PatrikEVP&Pres, LLY Dia&Obe, LLY USA
|
Tax withholdingCommon Stock | 1,844 | $645.61 | $1,190,504.84 |
DisclosureSEC source: 0000059478-24-000021 · wk-form4_1706909191.xml · nonDerivative · entry 2 Jonsson Patrik · CIK 0001786054 · EVP&Pres, LLY Dia&Obe, LLY USA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,221 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:26 UTC |
Jonsson PatrikEVP&Pres, LLY Dia&Obe, LLY USA
|
Exercise / conversionCommon Stock | 4,124 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000021 · wk-form4_1706909191.xml · nonDerivative · entry 1 Jonsson Patrik · CIK 0001786054 · EVP&Pres, LLY Dia&Obe, LLY USA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:28 UTC |
Ricks David ADirector · President, Chair, and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 29,611 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000023 · wk-form4_1706909271.xml · derivative · entry 6 Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,611 shares Expires 2024-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:28 UTC |
Ricks David ADirector · President, Chair, and CEO
|
Tax withholdingCommon Stock | 13,240 | $645.61 | $8,547,876.40 |
DisclosureSEC source: 0000059478-24-000023 · wk-form4_1706909271.xml · nonDerivative · entry 2 Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,814 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:28 UTC |
Ricks David ADirector · President, Chair, and CEO
|
Exercise / conversionCommon Stock | 29,611 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000023 · wk-form4_1706909271.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:29 UTC |
Yuffa IlyaEVP & President, LLY Int'l
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,702 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000025 · wk-form4_1706909331.xml · derivative · entry 3 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,702 shares Expires 2024-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:29 UTC |
Yuffa IlyaEVP & President, LLY Int'l
|
Tax withholdingCommon Stock | 1,664 | $645.61 | $1,074,295.04 |
DisclosureSEC source: 0000059478-24-000025 · wk-form4_1706909331.xml · nonDerivative · entry 2 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,012 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:29 UTC |
Yuffa IlyaEVP & President, LLY Int'l
|
Exercise / conversionCommon Stock | 3,702 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000025 · wk-form4_1706909331.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:32 UTC |
Hakim AnatEVP, GC & Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,442 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000027 · wk-form4_1706909506.xml · derivative · entry 3 Hakim Anat · CIK 0001685556 · EVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,442 shares Expires 2024-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:32 UTC |
Hakim AnatEVP, GC & Secretary
|
Tax withholdingCommon Stock | 1,967 | $645.61 | $1,269,914.87 |
DisclosureSEC source: 0000059478-24-000027 · wk-form4_1706909506.xml · nonDerivative · entry 2 Hakim Anat · CIK 0001685556 · EVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,664 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:32 UTC |
Hakim AnatEVP, GC & Secretary
|
Exercise / conversionCommon Stock | 4,442 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000027 · wk-form4_1706909506.xml · nonDerivative · entry 1 Hakim Anat · CIK 0001685556 · EVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 500 | $662.81 | $331,404.00 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 16 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,333,810 F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $662.65 to $663.025, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 200 | $661.63 | $132,326.00 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 15 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,334,310 Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 985 | $661.09 | $651,171.68 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 14 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,334,510 F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $660.5246 to $661.23, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 797 | $659.64 | $525,733.08 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 13 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,335,495 F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $659.185 to $660.0675, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,700 | $658.65 | $1,119,706.70 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 12 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,336,292 F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $658.11 to $658.94, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 600 | $657.40 | $394,438.80 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 11 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,337,992 F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $656.98 to $657.87, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,700 | $656.30 | $1,115,713.40 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 10 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,338,592 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $655.86 to $656.635, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,750 | $655.27 | $1,801,978.75 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,340,292 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $654.765 to $655.60, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,900 | $654.25 | $1,243,078.80 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,343,042 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $653.765 to $654.76, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 900 | $651.56 | $586,404.00 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,344,942 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $651.3174 to $651.83, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 815 | $650.73 | $530,344.14 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,345,842 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $650.235 to $651.00, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,931 | $649.80 | $3,204,178.59 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,346,657 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $649.185 to $650.00, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 7,424 | $648.60 | $4,815,191.55 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,351,588 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $648.115 to $649.11, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 8,696 | $647.53 | $5,630,938.27 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,359,012 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $647.07 to $648.0202, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 9,169 | $646.41 | $5,926,933.29 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,367,708 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $646.00 to $646.99, inclusive. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 21:00 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 35,506 | $645.28 | $22,911,382.69 |
DisclosureSEC source: 0001415889-24-002161 · form4-02012024_040201.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,376,877 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $645.00 to $645.95, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), and (15) to this Form 4. Read SEC document |
| January 30, 2024 Filed Jan 31, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,845 | $646.27 | $4,423,711.31 |
DisclosureSEC source: 0001415889-24-002047 · form4-01312024_040101.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,412,383 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $646.00 to $646.59, inclusive. Read SEC document |
| January 30, 2024 Filed Jan 31, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 69,370 | $645.11 | $44,751,488.81 |
DisclosureSEC source: 0001415889-24-002047 · form4-01312024_040101.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,419,228 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $645.00 to $645.95, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 29, 2024 Filed Jan 30, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 54,032 | $645.07 | $34,854,422.24 |
DisclosureSEC source: 0001415889-24-001974 · form4-01302024_040117.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,488,598 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $645.00 to $645.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| January 16, 2024 Filed Jan 17, 2024 21:12 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 19 | $634.57 | $12,056.83 |
DisclosureSEC source: 0000059478-24-000002 · wk-form4_1705525943.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,891 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| January 16, 2024 Filed Jan 17, 2024 21:14 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 16 | $634.57 | $10,153.12 |
DisclosureSEC source: 0000059478-24-000004 · wk-form4_1705526038.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,437 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| January 16, 2024 Filed Jan 17, 2024 21:15 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 15 | $634.57 | $9,518.55 |
DisclosureSEC source: 0000059478-24-000006 · wk-form4_1705526116.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,584 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| January 16, 2024 Filed Jan 17, 2024 21:19 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 16 | $634.57 | $10,153.12 |
DisclosureSEC source: 0000059478-24-000010 · wk-form4_1705526334.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,085 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| January 16, 2024 Filed Jan 17, 2024 21:17 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 23 | $634.57 | $14,595.11 |
DisclosureSEC source: 0000059478-24-000008 · wk-form4_1705526206.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,592 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| January 16, 2024 Filed Jan 17, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 100 | $646.17 | $64,617.00 |
DisclosureSEC source: 0001415889-24-001274 · form4-01172024_040101.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,542,630 Read SEC document |
| January 16, 2024 Filed Jan 17, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,080 | $645.55 | $697,188.60 |
DisclosureSEC source: 0001415889-24-001274 · form4-01172024_040101.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,542,730 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $645.005 to $645.985, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 200 | $639.13 | $127,826.00 |
DisclosureSEC source: 0001415889-24-001028 · form4-01122024_040107.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,543,810 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $638.96 to $639.30, inclusive. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,000 | $636.86 | $636,864.00 |
DisclosureSEC source: 0001415889-24-001028 · form4-01122024_040107.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,544,010 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.635 to $636.94, inclusive. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,721 | $635.94 | $1,730,403.62 |
DisclosureSEC source: 0001415889-24-001028 · form4-01122024_040107.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,545,010 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.53 to $636.45, inclusive. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,799 | $635.05 | $1,777,513.35 |
DisclosureSEC source: 0001415889-24-001028 · form4-01122024_040107.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,547,731 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.525 to $635.51, inclusive. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,200 | $633.91 | $760,692.00 |
DisclosureSEC source: 0001415889-24-001028 · form4-01122024_040107.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,550,530 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $633.525 to $634.17, inclusive. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,724 | $632.84 | $1,091,014.44 |
DisclosureSEC source: 0001415889-24-001028 · form4-01122024_040107.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,551,730 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.48 to $633.37, inclusive. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,200 | $631.67 | $758,006.40 |
DisclosureSEC source: 0001415889-24-001028 · form4-01122024_040107.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,553,454 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.22 to $632.215, inclusive. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,500 | $630.24 | $945,366.00 |
DisclosureSEC source: 0001415889-24-001028 · form4-01122024_040107.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,554,654 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.00 to $630.75, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7) and (8) to this Form 4. Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 800 | $636.29 | $509,030.40 |
DisclosureSEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,556,154 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.22 to $636.3825, inclusive. Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 21:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 900 | $635.74 | $572,167.80 |
DisclosureSEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,556,954 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.16 to $636.04, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.